CATALYST BIOSCIENCES, INC.·4

Nov 27, 5:01 PM ET

Levy Howard 4

4 · CATALYST BIOSCIENCES, INC. · Filed Nov 27, 2018

Insider Transaction Report

Form 4
Period: 2018-11-26
Levy Howard
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2018-11-26$4.63/sh+149$6907,709 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-11-2614987,118 total
    Exercise: $4.63Exp: 2027-07-11Common Stock (149 underlying)
Footnotes (1)
  • [F1]The Option vests monthly over a period of four years commencing June 15, 2017.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION